Potential vaccination strategy focuses on reactivating latent HIV.
Jonny
J
Patience
D016915:AIDS Vaccines / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000276:immunology* / Q000472:pathogenicity / Q000502:physiology; D054298:Human Immunodeficiency Virus Proteins / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D013601:T-Lymphocytes / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D014775:Virus Activation; D017735:Virus Latency
D016915:AIDS Vaccines; D054298:Human Immunodeficiency Virus Proteins